We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5019:TSEIdemitsu Kosan Co., Ltd. Analysis

Data as of 2026-07-17 - not real-time

¥1,259.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Idemitsu Kosan is trading at ¥1,259, comfortably above its 20‑day SMA (¥1,234.75) but still below the 50‑day (¥1,302.41) and 200‑day (¥1,275.67) averages, suggesting a neutral medium‑term trend. The MACD line sits above its signal (‑10.62 vs ‑20.74) with a positive histogram, indicating emerging bullish momentum, while the RSI of 48.8 reinforces a near‑neutral stance. Volume has been decreasing and the 30‑day volatility is elevated at 22.6%, yet the beta of only 0.19 points to low market‑wide correlation, tempering systematic risk. Valuation metrics are compelling: a trailing PE of 8.97 versus an industry average of 21.18, a PB of 0.80 and a price‑to‑sales of 0.19 place the stock in deep value territory, and the DCF‑derived fair value of ¥2,032 suggests roughly a 10% upside from current levels. However, fundamentals show pressure: revenue fell 6.6% year‑over‑year, profit margins are thin (2.1% net), free cash flow is negative, and debt‑to‑equity is high at 69.8, flagging balance‑sheet risk. The dividend yield of 2.85% with a modest payout ratio of 25.6% appears sustainable and adds an income cushion. Overall, the stock combines attractive valuation and dividend income with modest bullish technical signs, but the downside remains tied to earnings weakness, high leverage, and sector cyclicality.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • Price positioned just above key support (¥1,175.5)
  • Undervalued multiples relative to industry peers

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue contraction and thin profit margins
  • High debt‑to‑equity ratio increasing financial risk
  • Sustainable dividend providing yield cushion

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicating significant upside potential
  • Low valuation multiples (PE, PB) offering margin of safety
  • Strategic shift toward renewable and functional material businesses

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin2.12%
P/E Ratio9.0
ROE8.95%
ROA2.63%
Debt/Equity69.82
P/B Ratio0.8
Op. Cash Flow¥392.4B
Free Cash Flow¥-47528501248
Industry P/E21.2

Technical Analysis

TrendNeutral
RSI48.8
Support¥1,175.50
Resistance¥1,290.00
MA 20¥1,234.75
MA 50¥1,302.41
MA 200¥1,275.67
MACDBullish
VolumeDecreasing
Fear & Greed Index91.55

Valuation

Fair Value¥2,031.52
Target Price¥1,387.50
Upside/Downside10.21%
GradeUndervalued
TypeValue
Dividend Yield2.85%

Risk Assessment

Beta0.19
Volatility22.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.